Efficacy and safety of celecoxib in the treatment of acute pain due to ankle sprain in a Latin American and middle eastern population

Journal of International Medical Research

Volumn 37, Issue 6, 2009, Pages 1937-1951

  Cardenas Estrada, Eloy ^a   Oliveira, L G ^b   Abad, H L ^c   Elayan, F ^d   Khalifa, N ^e   El Husseini, T ^e  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b Clínica de Ortopedia e Fraturas   (Brazil)

^c HOSPITAL METROPOLITANO   (Ecuador)

^d Islamic Hospital   (Jordan)

^e Ain Shams University   (Egypt)

Author keywords

Ankle pain; Ankle sprain; Celecoxib; Cyclo oxygenase 2 (COX 2) selective NSAIDs; Loading dose; Non selective NSAIDs; Non steroidal anti inflammatory drugs (NSAIDs)

Indexed keywords

CELECOXIB; COLESTYRAMINE; DICLOFENAC; IBUPROFEN; KETOPROFEN; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; TIAPROFENIC ACID;

ADD ON THERAPY; ADULT; ANKLE SPRAIN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MULTICENTER STUDY; OPEN STUDY; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SOUTH AND CENTRAL AMERICA; VISUAL ANALOG SCALE;

EID: 74949143137     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700632     Document Type: Article

References (60)

1. Kannus P, Renstrom P: Treatment for acute tears of the lateral ligaments of the ankle. Operation, cast, or early controlled mobilization. J Bone Joint Surg Am 1991; 73: 305-312.
2. Wolfe MW, Uhl TL, Mattacola CG, et al: Management of ankle sprains. Am Fam Physician 2001; 63: 93-104.
3. Calabrese L, Rooney T: The Use of NSAIDs in Sports. New York: McGraw-Hill, 1986; pp 89-97.
4. Duncan JJ, Farr JE: Comparison of diclofenac sodium and aspirin in the treatment of acute sports injuries. Am J Sports Med 1988; 16: 656-659.
5. Bahamonde LA, Saavedra H: Comparison of the analgesic and anti-inflammatory effects of diclofenac potassium versus piroxicam versus placebo in ankle sprain patients. J Int Med Res 1990; 18: 104-111.
6. Moran M: An observer-blind comparison of diclofenac potassium, piroxicam and placebo in the treatment of ankle sprains. Curr Med Res Opin 1990; 12: 268-274.
7. Moran M: Double-blind comparison of diclofenac potassium, ibuprofen and placebo in the treatment of ankle sprains. J Int Med Res 1991; 19: 121-130.
8. McIlwain HH, Platt RD: Piroxicam versus naproxen in the treatment of acute musculoskeletal disorders in athletes. Am J Med 1988; 84: 56-60.
9. Slatyer MA, Hensley MJ, Lopert R: A randomized controlled trial of piroxicam in the management of acute ankle sprain in Australian Regular Army recruits. The Kapooka Ankle Sprain Study. Am J Sports Med 1997; 25: 544-553.
10. Calligaris A, Scaricabarozzi I, Vecchiet L: A multicentre double-blind investigation comparing nimesulide and naproxen in the treatment of minor sport injuries. Drugs 1993; 46(suppl 1): 187-190.
11. Dreiser RL, Riebenfeld D: A double-blind study of the efficacy of nimesulide in the treatment of ankle sprain in comparison with placebo. Drugs 1993; 46(suppl 1): 183-186.
12. McLatchie GR, Allister C, MacEwen C, et al: Variable schedules of ibuprofen for ankle sprains. Br J Sports Med 1985; 19: 203-206.
13. Campbell J, Dunn T: Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. J Accid Emerg Med 1994; 11: 178-182.
14. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-235.
15. Nadarajah A, Abrahan L, Lau FL, et al: Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. Singapore Med J 2006; 47: 534-542.
16. Gudis K, Sakamoto C: The role of cyclooxygenase in gastric mucosal protection. Digestive Dis Sci 2005; 50(suppl 1): S16-S23.
17. Brzozowski T, Konturek PC, Konturek SJ, et al: Role of prostaglandins in gastroprotection and gastric adaption. J Physiol Pharmacol 2005; 56(suppl 5): 33-55.
18. Seibert K, Zhang Y, Leahy K, et al: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994; 91: 12013-12017.
19. Otto JC, Smith WL: Prostaglandin endoperoxide synthases-1 and -2. J Lipid Mediat Cell Signal 1995; 12: 139-156.
20. Emery P: Clinical implications of selective cyclooxygenase-2 inhibition. Scand J Rheumatol Suppl 1996; 102: 23-28.
21. Simon LS: Nonsteroidal antiinflammatory drugs and their effects: the importance of COX-2 selectivity. J Clin Rheumatol 1996; 2: 135-140.
22. Ekman EF, Fiechtner JJ, Levy S, et al: Efficacy of celecoxib versus ibuprofen in the treatment of acute pain: a multicenter, double-blind, randomized controlled trial in acute ankle sprain. Am J Orthop 2002; 31: 445-451.
23. Petrella R, Ekman EF, Schuller R, et al: Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: results of a double-blind, randomized controlled trial. Clin J Sport Med 2004; 14: 225-231.
24. Yepes J, Ekman E, Levy S, et al: Efficacy of celecoxib versus diclofenac in the treatment of pain associated with acute ankle sprain: a multicenter, double blind, randomized trial. Ann Rheum Dis 2002; 61(suppl 1): abstract ABO507.
25. Singh G, Fort JG, Goldstein JL, et al: Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study. Am J Med 2006; 119: 255-266.
26. Goldstein JL, Correa P, Zhao WW, et al: Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Am J Gastroenterol 2001; 96: 1019-1027.
27. Mamdani M, Rochon PA, Juurlink DN, et al: Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ 2002; 325: 624-629.
28. Scheiman JM, Cryer B, Kimmey MB, et al: A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury. Clin Gastroenterol Hepatol 2004; 2: 290-295.
29. Leese PT, Hubbard RC, Karim A, et al: Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 2000; 40: 124-132.
30. Evangelou E, Tsianos G, Ioannidis JPA: Doctors' versus patients' global assessments of treatment effectiveness: empirical survey of diverse treatments in clinical trials. BMJ 2008; 336: 1287-1290.
31. Cleeland CS: Measurement of pain by subjective report. In: Advances in Pain Research and Therapy, Volume 12: Issues in Pain Measurement (Chapman CR, Loeser JD, eds). New York: Raven Press, 1989; pp 391-403.
32. Zelman DC, Gore M, Dukes E, et al: Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy. J Pain Symptom Manage 2005; 29: 401-410.
33. Celebrex prescribing information, revised January 2008. New York: GD Searle LLC, a division of Pfizer Inc (available at: http://media.pfizer.com/ files/products/uspi-celebrex.pdf).
34. Moore RA, Derry S, Makinson GT, et al: Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports. Arthritis Res Ther 2005; 7: R644-R665.
35. Silverstein FE, Faich G, Goldstein JL, et al: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA 2000; 284: 1247-1255.
36. García Rodríguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal antiinflammatory drugs. Lancet 1994; 343: 769-772. Erratum in: Lancet 1994; 343: 1048.
37. Langman MJ, Weil J, Wainwright P, et al: Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078. Erratum in: Lancet 1994; 343: 1302.
38. García Rodríguez LA, Cattaruzzi C, Troncon MG, et al: Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998; 158: 33-39.
39. Green D, Davies RO, Holmes GI, et al: Effects of diflunisal on platelet function and fecal blood loss. Clin Pharmacol Ther 1981; 30: 378-384.
40. Schafer AI: Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995; 35: 209-219.
41. Hubbard TJ, Hicks-Little CA: Ankle ligament healing after an acute ankle sprain: an evidence-based approach. J Athletic Training 2008; 43: 523-529.
42. Fong DTP, Chan YY, Mok KM, et al: Understanding acute ankle ligamentous sprain injury in sports. Sports Med Arthroscopy Rehabilitation Ther Technol 2009; 1: 1-14.
43. Brukner D, Khan K: Acute ankle injuries. In: Clinical Sports Medicine, 3rd edn. North Ryde: McGraw-Hill, 2006; p 612.
44. Gerber JP, Williams GN, Scoville CR, et al: Persistent disability associated with ankle sprains: a prospective examination of an athletic population. Foot Ankle Int 1998; 19: 653-660.
45. Verhagen RA, de Keizer G, van Dijk CN: Longterm follow-up of inversion trauma of the ankle. Arch Orthop Trauma Surg 1995; 114: 92-96.
46. Reza MF, Urakami Y, Mano Y: Evaluation of a new physical exercise taken from salat (prayer) as a short-duration and frequent physical activity in the rehabilitation of geriatric and disabled patients. Ann Saudi Med 2002; 22: 177-180.
47. Jordan KM, Arden NK, Doherty M, et al: EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145-1155.
48. Tannenbaum H, Peloso PM, Russell AS, et al: An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol 2000; 7(suppl A): 4A-16A.
49. American College of Rheumatology Subcommittee on Rheumatoid Arthritis: Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46: 328-346.
50. National Institute for Health and Clinical Excellence: Dyspepsia: managing dyspepsia in adults in primary care. Clinical Guideline 17, amended June 2005 (available at: http://www.nice.org.uk/cg017).
51. Nexium prescribing information, June 2009. Wilmington: AstraZeneca Pharmaceuticals (available at: http://www1.astrazenecaus. com/pi/Nexium.pdf).
52. Natsch S, Vinks MHAM, Voogt AK, et al: Anaphylactic reactions to proton-pump inhibitors. Ann Pharmacother 2000; 34: 474-476.
53. Lucas W, Schroy PC: Reversible ischemic colitis in a high endurance athlete. Am J Gastroenterol 1998; 93: 2231-2234.
54. Cheung R, Krishnaswami S, Kowalski K: Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebocontrolled study. Clin Ther 2007; 29(suppl): 2498-2510.
55. Malmstrom K, Fricke JR, Kotey P, et al: A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model. Clin Ther 2002; 24: 1549-1560.
56. Petri M, Hufman SL, Waser G, et al: Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis. J Rheumatol 2004; 31: 1614-1620.
57. Bertin P, Behier JM, Noel E, et al: Celecoxib is as efficacious as naproxen in the management of acute shoulder pain. J Int Med Res 2003; 31: 102-112.
58. Luyten FP, Geusens P, Malaise M, et al: A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Ann Rheum Dis 2007; 66: 99-106.
59. Ralha L, Oliveira L, Chahade W, et al: Efficacy and tolerability of celecoxib 200 mg bid versus diclofenac 75 mg bid in acute low back pain. J Rheumatol 2006; 12: S20, doi: 10.1097/01.rhu.0000226419.30363.7f (abstract presented at the XIVth Congress of the Pan-American League of Associations for Rheumatology).
60. Gimbel JS, Brugger A, Zhao W, et al: Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther 2001; 23: 228-241.